NCT00000950 - Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

Not specified

Primary Completion Date

May 31, 2002

Conditions

HIV InfectionsTuberculosis

Interventions

DRUG

Ethambutol hydrochloride

DRUG

Isoniazid

DRUG

Pyrazinamide

DRUG

Pyridoxine hydrochloride

DRUG

Rifampin

Trial Locations (13)

10003

Beth Israel Med Ctr, New York

10021

St Vincent's Hosp / Mem Sloan-Kettering Cancer Ctr, New York

10029

Mount Sinai Med Ctr, New York

19104

Univ of Pennsylvania at Philadelphia, Philadelphia

30308

Emory Univ, Atlanta

33136

University of Miami (Pediatric), Miami

70112

Tulane Univ School of Medicine, New Orleans

90502

Harbor UCLA Med Ctr, Torrance

96816

Queens Med Ctr, Honolulu

Univ of Hawaii, Honolulu

112032098

SUNY / Health Sciences Ctr at Brooklyn, Brooklyn

441091998

MetroHealth Med Ctr, Cleveland

900331079

Univ of Southern California / LA County USC Med Ctr, Los Angeles

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH